DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure and specificity of several triclocarban-binding single domain camelid antibody fragments

Abstract

The variable VHH domains of camelid single chain antibodies have been useful in numerous biotechnology applications due to their simplicity, biophysical properties, and abilities to bind to their cognate antigens with high affinities and specificity. Their interactions with proteins have been well-studied, but considerably less work has been done to characterize their ability to bind haptens. Here, a high-resolution structural study of three nanobodies (T4, T9, and T10) which have been shown to bind triclocarban (TCC, 3-(4-chlorophenyl)-1-(3,4-dichlorophenyl)urea) with near-nanomolar affinity shows that binding occurs in a tunnel largely formed by CDR1 rather than a surface or lateral binding mode seen in other nanobody-hapten interactions. Additional significant interactions are formed with a non-hypervariable loop, sometimes dubbed “CDR4”. A comparison of apo and holo forms of T9 and T10 shows that the binding site undergoes little conformational change upon binding of TCC. Structures of three nanobody-TCC complexes demonstrated there was not a standard binding mode. T4 and T9 have a high degree of sequence identity and bind the hapten in a nearly identical manner, while the more divergent T10 binds TCC in a slightly displaced orientation with the urea moiety rotated approximately 180° along the long axis of the molecule. In additionmore » to methotrexate, this is the second report of haptens binding in a tunnel formed by CDR1, suggesting that compounds with similar hydrophobicity and shape could be recognized by nanobodies in analogous fashion. Structure-guided mutations failed to improve binding affinity for T4 and T9 underscoring the high degree of natural optimization.« less

Authors:
 [1];  [2];  [2]; ORCiD logo [1]; ORCiD logo [2]
  1. Univ. of the Republic (UDELAR), Montevideo (Uruguay)
  2. Univ. of California, Davis, CA (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS); SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States). Advanced Light Source (ALS)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER); USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH); Univ. of California; National Science Foundation (NSF)
OSTI Identifier:
1569914
Alternate Identifier(s):
OSTI ID: 1461214
Grant/Contract Number:  
AC02-06CH11357; AC02-76SF00515; AC02-05CH11231; P41GM103393; GM105404; GM073210; GM082250; GM094625; P41GM103403; S10OD021527; MR-15-328599; 1330685
Resource Type:
Accepted Manuscript
Journal Name:
JMR. Journal of Molecular Recognition
Additional Journal Information:
Journal Volume: 32; Journal Issue: 1; Journal ID: ISSN 0952-3499
Publisher:
Wiley
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Tabares-da Rosa, Sofia, Wogulis, Linda A., Wogulis, Mark D., González-Sapienza, Gualberto, and Wilson, David K. Structure and specificity of several triclocarban-binding single domain camelid antibody fragments. United States: N. p., 2018. Web. doi:10.1002/jmr.2755.
Tabares-da Rosa, Sofia, Wogulis, Linda A., Wogulis, Mark D., González-Sapienza, Gualberto, & Wilson, David K. Structure and specificity of several triclocarban-binding single domain camelid antibody fragments. United States. https://doi.org/10.1002/jmr.2755
Tabares-da Rosa, Sofia, Wogulis, Linda A., Wogulis, Mark D., González-Sapienza, Gualberto, and Wilson, David K. Mon . "Structure and specificity of several triclocarban-binding single domain camelid antibody fragments". United States. https://doi.org/10.1002/jmr.2755. https://www.osti.gov/servlets/purl/1569914.
@article{osti_1569914,
title = {Structure and specificity of several triclocarban-binding single domain camelid antibody fragments},
author = {Tabares-da Rosa, Sofia and Wogulis, Linda A. and Wogulis, Mark D. and González-Sapienza, Gualberto and Wilson, David K.},
abstractNote = {The variable VHH domains of camelid single chain antibodies have been useful in numerous biotechnology applications due to their simplicity, biophysical properties, and abilities to bind to their cognate antigens with high affinities and specificity. Their interactions with proteins have been well-studied, but considerably less work has been done to characterize their ability to bind haptens. Here, a high-resolution structural study of three nanobodies (T4, T9, and T10) which have been shown to bind triclocarban (TCC, 3-(4-chlorophenyl)-1-(3,4-dichlorophenyl)urea) with near-nanomolar affinity shows that binding occurs in a tunnel largely formed by CDR1 rather than a surface or lateral binding mode seen in other nanobody-hapten interactions. Additional significant interactions are formed with a non-hypervariable loop, sometimes dubbed “CDR4”. A comparison of apo and holo forms of T9 and T10 shows that the binding site undergoes little conformational change upon binding of TCC. Structures of three nanobody-TCC complexes demonstrated there was not a standard binding mode. T4 and T9 have a high degree of sequence identity and bind the hapten in a nearly identical manner, while the more divergent T10 binds TCC in a slightly displaced orientation with the urea moiety rotated approximately 180° along the long axis of the molecule. In addition to methotrexate, this is the second report of haptens binding in a tunnel formed by CDR1, suggesting that compounds with similar hydrophobicity and shape could be recognized by nanobodies in analogous fashion. Structure-guided mutations failed to improve binding affinity for T4 and T9 underscoring the high degree of natural optimization.},
doi = {10.1002/jmr.2755},
journal = {JMR. Journal of Molecular Recognition},
number = 1,
volume = 32,
place = {United States},
year = {Mon Jul 23 00:00:00 EDT 2018},
month = {Mon Jul 23 00:00:00 EDT 2018}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 19 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Generation of llama single-domain antibodies against methotrexate, a prototypical hapten
journal, March 2007


Lateral recognition of a dye hapten by a llama VHH domain
journal, August 2001

  • Spinelli, Silvia; Tegoni, Mariella; Frenken, Leon
  • Journal of Molecular Biology, Vol. 311, Issue 1
  • DOI: 10.1006/jmbi.2001.4856

In Vitro Biologic Activities of the Antimicrobials Triclocarban, Its Analogs, and Triclosan in Bioassay Screens: Receptor-Based Bioassay Screens
journal, September 2008

  • Ahn, Ki Chang; Zhao, Bin; Chen, Jiangang
  • Environmental Health Perspectives, Vol. 116, Issue 9
  • DOI: 10.1289/ehp.11200

Nanobodies as therapeutics: big opportunities for small antibodies
journal, July 2016


A review of personal care products in the aquatic environment: Environmental concentrations and toxicity
journal, March 2011


Naturally occurring antibodies devoid of light chains
journal, June 1993

  • Hamers-Casterman, C.; Atarhouch, T.; Muyldermans, S.
  • Nature, Vol. 363, Issue 6428
  • DOI: 10.1038/363446a0

Effects of Triclocarban on Intact Immature Male Rat: Augmentation of Androgen Action
journal, October 2010


Potent enzyme inhibitors derived from dromedary heavy-chain antibodies
journal, July 1998


Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells
journal, July 2015

  • Rossotti, Martín; Tabares, Sofía; Alfaya, Lucía
  • Biochimica et Biophysica Acta (BBA) - General Subjects, Vol. 1850, Issue 7
  • DOI: 10.1016/j.bbagen.2015.03.009

Triclocarban Enhances Testosterone Action: A New Type of Endocrine Disruptor?
journal, November 2007

  • Chen, Jiangang; Ahn, Ki Chang; Gee, Nancy A.
  • Endocrinology, Vol. 149, Issue 3
  • DOI: 10.1210/en.2007-1057

Thermal Unfolding of a Llama Antibody Fragment:  A Two-State Reversible Process
journal, January 2001

  • Pérez, Janice M. J.; Renisio, Jean G.; Prompers, Jeanine J.
  • Biochemistry, Vol. 40, Issue 1
  • DOI: 10.1021/bi0009082

Llama Single Domain Antibodies as a Tool for Molecular Mimicry
journal, June 2005

  • Zarebski, Laura M.; Urrutia, Mariela; Goldbaum, Fernando A.
  • Journal of Molecular Biology, Vol. 349, Issue 4
  • DOI: 10.1016/j.jmb.2005.03.072

Single-domain antibody fragments with high conformational stability
journal, March 2002

  • Dumoulin, Mireille; Conrath, Katja; Van Meirhaeghe, Annemie
  • Protein Science, Vol. 11, Issue 3
  • DOI: 10.1110/ps.34602

Isolation of Alpaca Anti-Hapten Heavy Chain Single Domain Antibodies for Development of Sensitive Immunoassay
journal, December 2011

  • Kim, Hee-Joo; McCoy, Mark R.; Majkova, Zuzana
  • Analytical Chemistry, Vol. 84, Issue 2
  • DOI: 10.1021/ac2030255

VHH antibodies: emerging reagents for the analysis of environmental chemicals
journal, May 2016

  • Bever, Candace S.; Dong, Jie-Xian; Vasylieva, Natalia
  • Analytical and Bioanalytical Chemistry, Vol. 408, Issue 22
  • DOI: 10.1007/s00216-016-9585-x

Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens
journal, November 2008

  • De Simone, Emilio A.; Saccodossi, Natalia; Ferrari, Alejandro
  • Veterinary Immunology and Immunopathology, Vol. 126, Issue 1-2
  • DOI: 10.1016/j.vetimm.2008.06.015

Nanobody-Based Enzyme Immunoassay for Aflatoxin in Agro-Products with High Tolerance to Cosolvent Methanol
journal, August 2014

  • He, Ting; Wang, Yanru; Li, Peiwu
  • Analytical Chemistry, Vol. 86, Issue 17
  • DOI: 10.1021/ac502390c

Competitive Selection from Single Domain Antibody Libraries Allows Isolation of High-Affinity Antihapten Antibodies That Are Not Favored in the llama Immune Response
journal, September 2011

  • Tabares-da Rosa, Sofia; Rossotti, Martin; Carleiza, Carmen
  • Analytical Chemistry, Vol. 83, Issue 18
  • DOI: 10.1021/ac201824z

Inference of Macromolecular Assemblies from Crystalline State
journal, September 2007


Improving the targeting of therapeutics with single-domain antibodies
journal, January 2016


Nanobodies: Natural Single-Domain Antibodies
journal, June 2013


Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies
journal, April 1999

  • van der Linden, R. H. J.; Frenken, L. G. J.; de Geus, B.
  • Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, Vol. 1431, Issue 1
  • DOI: 10.1016/S0167-4838(99)00030-8

Three Camelid VHH Domains in Complex with Porcine Pancreatic α-Amylase: INHIBITION AND VERSATILITY OF BINDING TOPOLOGY
journal, April 2002

  • Desmyter, Aline; Spinelli, Silvia; Payan, Françoise
  • Journal of Biological Chemistry, Vol. 277, Issue 26
  • DOI: 10.1074/jbc.M202327200

Camelid Heavy-Chain Variable Domains Provide Efficient Combining Sites to Haptens
journal, February 2000

  • Spinelli, Silvia; Frenken, Leon G. J.; Hermans, Pim
  • Biochemistry, Vol. 39, Issue 6
  • DOI: 10.1021/bi991830w

Nanobody-based products as research and diagnostic tools
journal, May 2014


Works referencing / citing this record:

Role of the non‐hypervariable FR3 D‐E loop in single‐domain antibody recognition of haptens and carbohydrates
journal, July 2019

  • Henry, Kevin A.; Hussack, Greg; Kumaran, Jyothi
  • Journal of Molecular Recognition, Vol. 32, Issue 11
  • DOI: 10.1002/jmr.2805

Chemical shift assignments of a camelid nanobody against aflatoxin B1
journal, October 2018


Structure and development of single domain antibodies as modules for therapeutics and diagnostics
journal, October 2019

  • Hoey, Robert J.; Eom, Hyeyoung; Horn, James R.
  • Experimental Biology and Medicine, Vol. 244, Issue 17
  • DOI: 10.1177/1535370219881129